Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors during the central anxious system, conolidine modulates alternate molecular targets. A Science Innovations review observed that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://isconolidinearealpainreli08296.blogpostie.com/59567032/considerations-to-know-about-alternative-natural-pain-relief-to-replace-traditional-painkillers